drugset / Trial / NCT03685747

Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis

NCT03685747

Phase 1 Completed 4 enrolled Thomas Jefferson University
NaSingle-groupOpen-labelBasic science

Summary

Vancomycin is the most commonly used empiric treatment for infectious peritonitis in patients on peritoneal dialysis. Current dosing and monitoring for safety and efficacy is empiric, especially for those on rapid-cycling modalities. The goal of this study is to understand the pharmacokinetics of vancomycin in patients on rapid-cycling peritoneal dialysis modalities in order to derive an optimal dosing regimen.

Timeline

Start
2018-11-15
Primary completion
2020-08-30
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified 20 mg/kg Other